Clinical Trials
10 trialsNCT03891576 2025-01-17
Newton
Mario Negri Institute for Pharmacological Research
Phase 2 Terminated
NCT00074165 2023-07-06
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT04631211 2023-05-25
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
Cellphire Therapeutics, Inc.
Phase 2 Terminated
NCT02074436 2022-07-19
PROBLEMA
Emory University
Phase 2 Terminated
NCT03303950 2022-05-05
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
University of Utah
Phase 2 Terminated
NCT03195010 2019-10-21
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
Fred Hutchinson Cancer Center
Phase 2 Terminated
NCT01676961 2018-10-15
Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy
NYU Langone Health
Phase 2 Terminated
NCT02227576 2018-04-25
PLATUM
University Hospital, Lille
Phase 2 Terminated
NCT01484314 2017-03-15
Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT01500538 2016-02-15
VEIL
Peter MacCallum Cancer Centre, Australia
Phase 2 Terminated